{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 449581249
| IUPAC_name = ethyl 4-[6-(diaminomethylideneamino)hexanoyloxy]benzoate
| image = Gabexate.svg
| width = 250
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|gabexate}}
| legal_UK =  
| legal_US =  
| routes_of_administration =  
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!--Identifiers-->
| IUPHAR_ligand = 7863
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 39492-01-8
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 3447
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 87563
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 4V7M9137X9
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08004
|  ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 3329
| smiles = O=C(Oc1ccc(cc1)C(=O)OCC)CCCCC/N=C(\N)N
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C16H23N3O4/c1-2-22-15(21)12-7-9-13(10-8-12)23-14(20)6-4-3-5-11-19-16(17)18/h7-10H,2-6,11H2,1H3,(H4,17,18,19)
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = YKGYIDJEEQRWQH-UHFFFAOYSA-N
<!--Chemical data-->
| C=16 | H=23 | N=3 | O=4
| molecular_weight = 311.37 g/mol
| density =  
}}

'''Gabexate''' is a [[serine protease inhibitor]] which is used therapeutically (as gabexate [[mesilate]]) in the treatment of [[pancreatitis]], [[disseminated intravascular coagulation]],<ref name="pmid12649382">{{cite journal |vauthors=Yuksel M, Okajima K, Uchiba M, Okabe H |title=Gabexate mesilate, a synthetic protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappaB and activator protein-1 in human monocytes |journal=J. Pharmacol. Exp. Ther. |volume=305 |issue=1 |pages=298–305 |year=2003 |pmid=12649382 |doi=10.1124/jpet.102.041988 |url=http://jpet.aspetjournals.org/cgi/reprint/305/1/298.pdf}}</ref> and as a regional [[anticoagulant]] for [[haemodialysis]].<ref name="pmid8786777">{{cite journal |vauthors=Cavallini G, Tittobello A, Frulloni L, Masci E, Mariana A, Di Francesco V |title=Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group |journal=N. Engl. J. Med. |volume=335 |issue=13 |pages=919–23 |year=1996 |pmid=8786777 |doi= 10.1056/NEJM199609263351302|url=http://content.nejm.org/cgi/reprint/335/13/919.pdf}}</ref>

== References ==
{{Reflist}}

[[Category:Guanidines]]
[[Category:Benzoates]]
[[Category:Ethyl esters]]


{{blood-drug-stub}}